MORGAN STANLEY

Position in CADL — Candel Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Position in CADL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$285,320

-$471,953 QoQ

Shares Held

58,229

-56.6% QoQ

Ownership

0.079%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 98.07655978979545.ToString("F0")% Shared 0.ToString("F0")% None 1.9234402102045374.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. CADL ranks #313 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$285,320	58,229	-56.6%	Shares	Defined	2026-05-15
2025-12-31	$757,273	134,031	+76.5%	Shares	Defined	2026-05-27
2025-09-30	$387,297	75,941	-33.2%	Shares	Defined	2026-05-27
2025-06-30	$575,429	113,722	+82.0%	Shares	Defined	2025-08-15
2025-03-31	$352,987	62,476	-17.0%	Shares	Defined	2025-05-15
2024-12-31	$653,385	75,275	+16.8%	Shares	Defined	2025-05-15
2024-09-30	$446,518	64,433	+231.1%	Shares	Defined	2025-05-14
2024-06-30	$120,639	19,458	+21050.0%	Shares	Defined	2025-05-14
2022-12-31	$164	92	-98.3%	Shares	Defined	2023-02-14
2022-09-30	$16,579	5,280	+14.3%	Shares	Defined	2022-11-14
2022-06-30	$14,972	4,621	-0.6%	Shares	Defined	2022-10-27
2022-03-31	$23,673	4,651	-1.5%	Shares	Defined	2022-10-27
2021-12-31	$36,925	4,722	—	Shares	Defined	2022-02-14
No filing history on record for this holder in this stock.